Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 23.48 Min. order: 1 piece ★★★★★ 4.7 (92 reviews) Sold : Login>>
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 5.0 (25 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 22.07 Min. order: 1 piece ★★★★★ 4.6 (38 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.4 (79 reviews) Sold : Login>>
CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 28.84 Min. order: 1 piece ★★★★★ 4.0 (206 reviews) Sold : Login>>